UK Court to Decide Whether Children and Teenagers Can Consent to Taking Puberty-Blocking Drugs and Cross-Sex Hormones

The Tavistock and Portman NHS Foundation Trust building in London, England. | YouTube/Sky News

The question of whether children and teenagers can consent to taking puberty-blocking drugs and cross-sex hormones to thwart their bodies natural growth as part of transgender experimentation will be adjudicated this week at the U.K.’s highest court.

The case is being brought by attorneys for Susan Evans against the Tavistock and Portman National Health Service which operate the lone gender identity clinic in the nation. Evans is a psychiatric nurse and psychoanalytic psychotherapist who believes the medicalization of gender in young people is experimental and carries lifelong, harmful consequences.

According to The U.K. Times, Evans’ lawyers will stress that providing puberty blockers and opposite-sex hormones at Tavistock for children age 18 and younger is against the law because minors are incapable of giving consent.

“There are so many unanswered questions that include the age at start, reversibility, serious adverse health events, long-term effects on mental health, neurological effects on cognitive functioning, the effect on bone density, circulatory systems and sexual functioning in adulthood,” a crowdfunding page for Evans asserts.

“We cannot stand by and watch young people be part of an experimental medical treatment that exposes them to very significant risks.”

In 2004, Evans raised concerns about practices within the clinic. Though an internal inquiry was conducted, she ultimate left feeling nothing had changed substantially.

The lawyers representing Evans are also representing a mother, whose identity has not been disclosed, of a 15-year-old autistic girl who’s on the waiting list for the Gender Identity Development Service.

Click here to read more.

SOURCE: Christian Post, Brandon Showalter